DAM
ZYNE

Deltec Asset Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Deltec Asset Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-475,000
Closed -$606K – 177
2023
Q3 		$606K Buy
+475,000
New +$415K 0.14% 104

Deltec Asset Management's ZYNE Position: Q4 2023 in Review

Deltec Asset Management sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 475,000 shares — an estimated $606K sold.

Deltec Asset Management first reported a position in ZYNE in Q3 2023 and held it in 1 quarter. The position peaked at $606K in Q3 2023. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

  • Deltec Asset Management reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
  • Deltec Asset Management sold 475,000 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $606K.
  • Deltec Asset Management first reported a position in Zynerba Pharmaceuticals, Inc in Q3 2023 and held it in 1 quarter.
  • Deltec Asset Management's Zynerba Pharmaceuticals, Inc position peaked at $606K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on Deltec Asset Management's 13F filing for Q4 2023, filed 22 Jan 2024.